Literature DB >> 6105289

Congenital abnormalities in baby born to cytarabine treated mother.

V M Wagner, J S Hill, D Weaver, R L Baehner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6105289     DOI： 10.1016/s0140-6736(80)92986-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Treatment of promyelocytic leukemia during pregnancy. A case report and review of the literature.

Authors:  H H Bartsch; D Meyer; A T Teichmann; C P Speer
Journal:  Blut       Date:  1988-07

Review 2.  Management of Hematologic Malignancies: Special Considerations in Pregnant Women.

Authors:  Odelia Amit; Merav Barzilai; Irit Avivi
Journal:  Drugs       Date:  2015-10       Impact factor: 9.546

3.  Teratogenic effects in a case of maternal treatment for acute myelocytic leukaemia--neonatal and infantile course.

Authors:  A Artlich; J Möller; A Tschakaloff; E Schwinger; K Kruse; L Gortner
Journal:  Eur J Pediatr       Date:  1994-07       Impact factor: 3.183

Review 4.  Species sensitivities and prediction of teratogenic potential.

Authors:  J L Schardein; B A Schwetz; M F Kenel
Journal:  Environ Health Perspect       Date:  1985-09       Impact factor: 9.031

Review 5.  Cancer treatment in pregnant women.

Authors:  Pawel Basta; Anna Bak; Krzysztof Roszkowski
Journal:  Contemp Oncol (Pozn)       Date:  2014-10-18

6.  Expression of Fibroblast Growth Factor 4 in a Rat Model of Polydactyly of the Thumb Induced by Cytarabine.

Authors:  Xin Zhao; Wentao Yang; Guancong Li; Haoran Dong; Jianlun Hou; Zhiwei Cao; Dehong Guan
Journal:  Med Sci Monit       Date:  2020-08-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.